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Abstract
 
Alymphoplasia (
 
aly
 
) mice, which carry a point mutation in the nuclear factor 
 
k
 
B–inducing ki-
nase (NIK) gene, are characterized by the systemic absence of lymph nodes and Peyer’s
patches, disorganized splenic and thymic architectures, and immunodeficiency. Another
unique feature of 
 
aly/aly
 
 mice is that their peritoneal cavity contains more B1 cells than normal
and 
 
aly/
 
1
 
 mice. Transfer experiments of peritoneal lymphocytes from
 
 aly/aly
 
 mice into re-
combination activating gene (RAG)-2
 
2/2
 
 mice revealed that B and T cells fail to migrate to
other lymphoid tissues, particularly to the gut-associated lymphatic tissue system. In vivo hom-
ing defects of 
 
aly/aly
 
 peritoneal cells correlated with reduction of their in vitro chemotactic re-
sponses to secondary lymphoid tissue chemokine (SLC) and B lymphocyte chemoattractant
(BLC). The migration defect of 
 
aly/aly
 
 lymphocytes was not due to a lack of expression of
chemokines and their receptors, but rather to impaired signal transduction downstream of the
receptors for SLC, indicating that NIK is involved in the chemokine signaling pathway known
to couple only with G proteins. The results showed that the reduced serum levels of immuno-
globulins (Igs) and the absence of class switch to IgA in 
 
aly/aly
 
 mice are due, at least in part, to
a migration defect of lymphocytes to the proper microenvironment where B cells proliferate
and differentiate into Ig-producing cells.
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2/2
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Introduction
 
Recent studies indicate that the development of structur-
ally and functionally normal lymphoid organs is a complex
process involving several members of the TNFR super-
 
family. Mice deficient for lymphotoxin (LT)
 
1
 
 
 
a
 
 (1, 2) or
LT
 
b
 
R (3), each of which interacts with membrane LT
heterotrimer (LT
 
a
 
1
 
b
 
2) and other ligands, such as LIGHT
(4), are characterized by a severe defect in the formation of
LNs, a complete absence of Peyer’s patches (PPs) and a
profound disturbance in the organization of the spleen, in-
cluding the absence of germinal centers (GCs) and follicu-
lar dendritic cell (FDC) network. Mice deficient for either
TNF (5) or TNFRI (6, 7) show a defect in the organiza-
tion of the spleen (loss of GCs and FDC network), but re-
tain the ability to form LNs or PPs. Studies on the mecha-
nism of disturbed LN formation by bone marrow (BM)
transplantation (8) or administration of the soluble LT
 
b
 
R-
Ig fusion protein during pregnancy (9, 10) have shown that
there is a developmental window during which LT-pro-
ducing cells must interact with LT-sensitive cells to trigger
 
the formation of LNs and PPs. In LT
 
a
 
2/2
 
 mice, formation
of FDC clusters and GCs were restored by transplantation
of normal BM cells (11) and subsequently, LT
 
a
 
-producing
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Abbreviations used in this paper:
 
 
 
aly
 
, alymphoplasia; BLC, B lymphocyte
chemoattractant; BLR1, Burkitt’s lymphoma receptor 1; BM, bone mar-
row; CCR, CC chemokine receptor; ELC, EBV-induced molecule 1
ligand chemokine; FDC, follicular dendritic cell; GALT, gut-associated
lymphatic tissue; GAPDH, glyceraldehyde 3-phosphate dehydrogenase;
GC, germinal center; LT, lymphotoxin; LP, lamina propria; MLN, me-
senteric LN; NF-
 
k
 
B, nuclear factor 
 
k
 
B; NIK, NF 
 
k
 
B–inducing kinase;
PEC, peritoneal cavity; PP, Peyer’s patch; RAG, recombination activat-
ing gene; SLC, secondary lymphoid tissue chemokine. 
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B cells were shown to provide the essential signal for in-
duction and maintenance of the lymphoid architecture
necessary for GC formation (12, 13).
Alymphoplasia (
 
aly
 
) mice, which carry a natural point
mutation in the gene encoding nuclear factor 
 
k
 
B–inducing
kinase (NIK) (14), represent another model for the abnor-
mal development of lymphoid organs, being characterized
by the systemic absence of LNs and PPs, disorganized
splenic architecture, and immunodeficiency (15). Because
 
aly
 
-type NIK affects the signaling pathway of LT
 
b
 
R (14),
which is exclusively expressed by nonlymphoid cells (16,
17), it is natural to interpret that the 
 
aly/aly
 
 phenotypes are
due to the defect of LT
 
b
 
R signaling in non-BM–derived
cells. However, 
 
aly/aly
 
 mice have unique features that are
not shared by LT
 
b
 
R
 
2/2
 
 and LT
 
a
 
2/2
 
 mice: disturbed thy-
mic structure, depressed T cell functions, and reduced
numbers of mature B cells in BM, spleen, and peripheral
blood (15, 18, 19). Furthermore, spleen, mesenteric LNs
(MLNs), and PPs remain atrophic when 
 
aly/aly
 
 BM cells
are transferred to irradiated wild-type mice (15). In con-
trast, LT
 
a
 
2/2
 
 BM cells have no homing defect to second-
ary lymphoid organs (8). The results suggest the presence
of a homing defect in 
 
aly/aly
 
 lymphocytes.
Another feature of 
 
aly/aly 
 
lymphocytes that suggests
their migration defect is a higher B1/B2 cell ratio in their
peritoneal cavity (PEC) than normal mice (14). More than
20 years ago, Husband and Gowans (20) suggested a link
between PEC cells and antigen-specific B cells in the lam-
ina propria (LP) of the rat small intestine. Approximately
half of the IgA plasma cells in the LP of intestine appeared
to be derived from PEC cells, suggesting that frequent mi-
gration of lymphocytes may take place between PEC and
GALT (21, 22). Although chemokines responsible for
PEC lymphocyte migration to secondary lymphoid organs
have not been identified, several chemokines are shown to
be involved in the constitutive homing of B lymphocytes
to their proper locations within lymphoid organs. Mice
with targeted disruption of the gene for Burkitt’s lym-
phoma receptor 1 (BLR1; also known as CXC chemokine
receptor 5 [CXCR5]), lack functional GCs in the spleen
with impaired B lymphocyte recirculation (23). The ligand
for BLR1, termed B lymphocyte chemoattractant (BLC)
or B cell attracting chemokine 1 (BCA-1), is shown to
promote migration of B lymphocytes in lymphoid follicles
(24, 25). Another chemokine, secondary lymphoid tissue
chemokine (SLC; also known as 6Ckine, Exodus-2, or
thymus-derived chemotactic agent 4 [TCA-4]), stimulates
the chemotaxis of naive T, memory T, and B cells (26–
29). Recently, targeted disruption of the gene for CC
chemokine receptor (CCR)7,
 
 
 
one of the receptors for
SLC, revealed that this receptor is important for T, B, and
dendritic cells to migrate to the proper microenviron-
ments, to initiate an antigen-specific immune response,
and to establish a functional architecture of the secondary
lymphoid tissues (30). 
Here, we report that 
 
aly/aly
 
 mice had no IgA
 
1
 
 B cells in
LP of small intestine, and that 
 
aly/aly
 
 PEC lymphocytes
have a migration defect to the gut-associated lymphoid tis-
 
sue (GALT) system as well as spleen. We have also demon-
strated that the 
 
aly
 
 mutation in the NIK gene blocks sig-
naling from the receptors for SLC, providing the first
demonstration that NIK is involved in signal transduction
of seven transmembrane–type receptors.
 
Materials and Methods
 
Mice. aly/aly
 
, 
 
aly/
 
1
 
, and recombination activating gene
(RAG)-2
 
2/2
 
 mice were maintained under specific-pathogen free
conditions and LT
 
a
 
2/2
 
 mice were kept in conventional condi-
tions at the animal facility of the Department of Medical Chem-
istry, Kyoto University, and used between 10 and 14 wk of age.
 
Cell Preparation and Adoptive Transfer. 
 
PEC cells were har-
vested by flushing the peritoneum with 10 ml of RPMI 1640
medium containing 2% FCS, washed twice, and resuspended in
PBS. A total of 1.3 
 
3 
 
10
 
7 
 
cells from 
 
aly/aly
 
 or 
 
aly/
 
1
 
 mice, and
3 
 
3
 
 10
 
7 
 
cells from LT
 
a
 
2/2
 
 mice, were injected intraperitoneally
into RAG-2
 
2/2
 
 recipient mice.
 
Flow Cytometry Analysis. 
 
The following antibodies were
used: FITC-conjugated anti-B220 (PharMingen), anti-IgM
(Southern Biotechnology Associates), anti-CD3 (PharMingen),
PE-conjugated anti-IgA (Southern Biotechnology Associates),
and anti–Mac-1 (PharMingen). All analyses were performed on a
FACSCalibur™ (Becton Dickinson). Data were obtained on 2 
 
3
 
10
 
4
 
 viable cells, as determined by forward light scatter intensity
and propidium iodide exclusion.
 
Quantification of Plasma Cells and T Cells. 
 
Recipient mice
were killed 3–6 wk after transfer. RAG-2
 
2/2
 
 mice injected with
LT
 
a
 
2/2 
 
PEC cells were analyzed 12 wk after transfer. A standard
procedure was used to prepare single cell suspensions from PEC,
spleen, BM obtained from two femurs, and MLNs and LP of
small intestine. The percentages of IgA plasma cells in the LP of
the small intestine and MLNs were determined by FACS
 
®
 
. The
percentages of plasma cells in all lymphoid tissues were deter-
mined after cytocentrifuge preparation (Cytospin 3; Shandon,
Inc.), intracytoplasmic staining with FITC-labeled anti-IgM,
anti-IgA, and anti-IgG (PharMingen), and counterstaining with
DAPI (Wako Pure Chemicals) to visualize nuclei. The slides
were examined with a fluorescence microscope. The total num-
ber of T cells present in each organ was calculated from the fre-
quency estimated by immunofluorescence analysis and the total
number of cells recovered in each organ.
 
ELISA. 
 
Total IgM, IgA, and IgG in the sera were measured
by a modification of the sandwich ELISA described previously
(31). In brief, microtitration plates (Corning) were coated with
goat anti–mouse IgM (Southern Biotechnology Associates), goat
anti–mouse IgA (Cappel Laboratories), or anti–mouse IgG
(Kirkegaard & Perry Laboratories) antibodies and were blocked
with BSA. After incubation with the serum samples, alkaline
phosphatase–conjugated goat anti–mouse IgM and IgG antibod-
ies (Southern Biotechnology Associates), or goat anti–mouse IgA
antibody (Zymed Laboratories) was applied. The plates were
washed and developed using 
 
p
 
-nitrophenyl phosphate (Sigma
Chemical Co.). Absorbency was measured using an ELISA
reader.
 
Chemotaxis. 
 
Cell suspensions were prepared from spleen and
PEC, and were incubated for 2 h in RPMI 1640 medium sup-
plemented with 10% FCS, with or without 20 
 
m
 
g/ml LPS
(Sigma Chemical Co.). Chemotaxis assays were performed as de-
scribed (32), using 10
 
6
 
 total cells per 5-
 
m
 
m transwell (Corning
Costar Corp.). Cells that migrated to the lower chamber were 
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enumerated by collecting events for a fixed time (60 s) under a
constant sheath pressure on a FACSCalibur™. By counting a 1:10
dilution (in the case of SLC) and 1:20 dilution of input cells
(for BLC) in the same way, we determined the absolute number
of cells that transmigrated. To determine which subsets of cells
were migrated, the cells from the lower chamber were stained
with antibodies (PharMingen) as follows: FITC-conjugated anti-
IgM in combination with PE-conjugated anti–Mac-1 and/or
PE-conjugated anti-CD5 for PEC cells; FITC-conjugated anti-
B220 in combination with PE-conjugated anti-CD3 for spleen
cells.
 
Northern Blot Analysis. 
 
5–10 
 
m
 
g of total RNA from spleen,
PEC cells, and small intestine was subjected to electrophoresis,
transferred to Hybond N
 
1
 
 membranes (Amersham Pharmacia
Biotech), and probed with randomly primed 
 
32
 
P-labeled mouse
cDNA probes for chemokines BLC, SLC, and EBV-induced
molecule 1 ligand chemokine (ELC), and chemokine receptors
BLR1 and CCR7. Filters were rehybridized with the glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) probe. All probes
were cloned PCR products from wild-type splenic RNA. For
chemokine receptor expression, RNA was prepared from un-
stimulated or LPS-stimulated splenic and PEC cells (20 
 
m
 
g/ml
LPS for 2 h).
 
Electrophoretic Mobility Shift Assay. 
 
PEC cells from 10-wk-
old 
 
aly/aly
 
 and 
 
aly/
 
1
 
 mice kept in specific-pathogen free condi-
tions were stimulated with SLC (500 ng/ml) for 15 and 30 min.
Nuclear extracts were prepared according to the protocol de-
scribed (33). Consensus and mutant double-stranded oligonucle-
otides encoding NF-
 
k
 
B and Oct-1 binding sequence were end-
labeled with [
 
g
 
-
 
32
 
P]ATP using T4 polynucleotide kinase (Takara
Biotech). For competition and supershift assay, cold or mutant
oligonucleotide, or 1 
 
m
 
g of antibodies (Santa Cruz Biotechnol-
ogy) was added to the reaction. The samples were loaded onto
6% nondenaturing polyacrylamide gel and run in 0.25
 
3
 
 Tris-
borate buffer. The resultant DNA–protein complexes were de-
tected by autoradiography.
 
Results
 
Peritoneal Lymphocytes from aly/aly Mice Fail to Generate
IgA Plasma Cells in the GALT System of RAG-2
 
2/2
 
 Mice.
 
Two unique features of 
 
aly/aly
 
 mice, abundant B1 cells in
the PEC (Fig. 1, A and B) and the complete absence of the
B cell populations, B220
 
1
 
IgM
 
1
 
 small lymphocytes, and
B220
 
2
 
IgA
 
1
 
 plasma cells (our unpublished results) in LP of
the small intestine (Fig. 1, C and D) led us to suspect that
 
aly/aly
 
 PEC cells may have a migration defect to LP, al-
though the lack of IgA plasma cells in LP can be partially
explained by the lack of PPs, which normally contains the
B2 cell precursors of plasma cells (20, 34–37). Therefore,
we transferred PEC cells from 
 
aly/aly
 
 and 
 
aly/
 
1
 
 mice into
the PEC of RAG-2
 
2/2 mice and analyzed the lymphoid
tissues 3 and 6 wk after the transfer. First, FACS® analyses
revealed that no B2202IgA1 cells could be detected in LP
or MLNs of RAG-22/2 mice transferred with aly/aly peri-
toneal lymphocytes. By contrast, aly/1 peritoneal B cells
injected into RAG-22/2 mice migrated to MLNs and in-
testinal LP, where they gave rise to IgA plasma cells (Fig. 2,
A and B). In agreement with these results, the PEC of
RAG-22/2 mice injected with aly/aly lymphocytes con-
tained more B1 cells than the PEC of RAG-22/2 mice in-
jected with aly/1 lymphocytes (Fig. 2 C). The absence of
IgA plasma cells reflects a homing defect to the GALT sys-
tem and not a defect in class switching because aly/aly lym-
phocytes can produce IgA by in vitro culture in the pres-
ence of cytokines. When 4 3 105 PEC cells were cultured
for 7 d with IL-5 (100 U/ml), the Ig levels (ng/ml) in the
culture supernatants were as follows: IgM (784.37 6
193.38), IgG (200.55 6 14.75), and IgA (10.04 6 2.91) for
aly/aly PEC cells; and IgM (825.66 6 245.32), IgG (232.94 6
30.01), and IgA (13.03 6 4.32) for aly/1 PEC cells. Inter-
Figure 1. Abundant B1 cells in the PEC and
complete absence of B cell populations in LP of
aly/aly mice. (A) Flow cytometric analysis of PEC
cells from aly/aly and aly/1 mice. A total of 2 3
104 cells were analyzed for IgM in combination
with Mac-1. The numbers are the percentages of
B1 (IgM1Mac-11) and B2 (IgM1Mac-12) cells. (B)
Total numbers of PEC cells in aly/aly and aly/1
mice, as calculated by (percentage of indicated cells)
3 (number of viable cells). (C and D) Flow cyto-
metric analysis of LP cells of aly/aly and aly/1
mice, stained with FITC-conjugated anti-B220 and
PE-conjugated anti-IgM or anti-IgA. The numbers
are the percentages of B cells (B2201IgM1) and
plasma cells (B2202IgA1).1480 aly Defect in Chemokine Receptor Signaling and Homing
estingly, LTa2/2 PEC cells did not show any homing de-
fect to the GALT system (Fig. 2, A and B).
FACS® results were further confirmed and extended by
staining of fixed cytocentrifuge preparations of LP and
MLN lymphocytes for IgM, IgA, and IgG. As shown in
Table I, reconstitution of IgA or IgG plasma cells in LP of
the small intestine was not observed when PEC cells from
aly/aly were transferred to RAG-22/2 mice, whereas LP of
RAG-22/2 mice injected with aly/1 PEC cells contained
many IgA plasma cells and a few IgG plasma cells. On the
other hand, we did not observe any IgM plasma cells in LP
of normal C57BL/6 or BALB/c mice (data not shown), or
RAG-22/2 mice transferred with PEC cells from aly/aly or
aly/1 mice (Table I).
No IgM, IgA, or IgG plasma cells could be identified in
MLNs of RAG-22/2 mice injected with aly/aly PEC cells.
On the contrary, MLNs of RAG-22/2 mice injected with
aly/1 PEC cells contained IgA, IgM, and IgG plasma cells,
and the percentage of IgA plasma cells was at least two
times higher than that in LP. These results strongly suggest
that the absence of IgA plasma cells in the LP of aly/aly
mice is due not only to the lack of PPs, but also to a defect
of PEC cells to repopulate the GALT system with IgA
plasma cells.
Migration Defect of aly/aly PEC Cells Is Not Restricted to
Either GALT System or B Cells.  3 wk after transfer, the
spleen or BM of RAG-22/2 mice transferred with aly/aly
peritoneal B cells contained very few IgM or IgG and no
IgA plasma cells (Table I, and data not shown). On the
contrary, spleen of RAG-22/2 mice injected with aly/1
peritoneal B cells contained many IgM or IgG plasma cells,
and less but a significant number of IgA plasma cells, whereas
their BM contained ,0.5% each of plasma cells expressing
various isotypes (Table I, and data not shown). Although
Figure 2. Transfer of PEC cells from aly/
aly mice fails to generate IgA plasma cells in
GALT of RAG-22/2 mice. Flow cytometric
analysis of LP cells (A) and MLNs (B) de-
rived from RAG-22/2 mice, RAG-22/2
mice injected with 1.3 3 107 PEC cells from
aly/aly and aly/1 mice, and 3 3 107 PEC
cells from LTa2/2 mice, at 6 and 12 wk, re-
spectively, after the transfer. A total of 2 3
104 cells were analyzed for B220 in combi-
nation with IgA. The numbers are the per-
centages of IgA plasma cells (B2202IgA1).
(C) RAG-22/2 mice, RAG- 22/2 mice that
were injected intraperitoneally with PEC
cells from aly/aly and aly/1 mice 3 wk pre-
viously, and RAG-22/2 mice at 12 wk after
injection with LTa2/2 PEC cells. A total of
2 3 104 cells were analyzed for IgM in com-
bination with Mac-1. The numbers are the
percentages of B1 (IgM1Mac-11) and B2
(IgM  1Mac-12) cells.
Table I. Impaired Generation of Plasma Cells in RAG-22/2 Mice Transferred with aly/aly PEC Cells
Percent IgM Percent IgA Percent IgG
aly/aly aly/+ aly/aly aly/+ aly/aly aly/+
LPLs (3 wk) 0 0 0 2.33 6 0.81 0 ,1
LPLs (6 wk) 0 0 0 5.66 6 1.36 0 ,1
MLN (3 wk) 0 ,1 0 7.86 6 1.20 0 ,1
MLN (6 wk) 0 3.66 6 3.12 0 11.66 6 3.93 0 ,1
Spleen (3 wk) ,1 2.27 6 0.55 0 ,1 0 1.66 6 0.57
Spleen (6 wk) ,1 7.10 6 3.35 0 1.37 6 0.47 ,1 3.33 6 1.15
Fixed cytocentrifuge preparations of LP lymphocytes (LPLs), MLNs, and spleen cells from RAG-22/2 mice injected with PEC cells from aly/aly and
aly/+ mice were stained for intracytoplasmic IgM, IgA, and IgG, and counterstained with DAPI to visualize nuclei. The percentage of plasma cells
in total cells represents mean 6 SE from three transfer experiments.1481 Fagarasan et al.
IgM-secreting cells in normal mice generally represent
,1% of the total number of splenic cells, in RAG-22/2
mice injected with aly/1 lymphocytes the IgM plasma cells
represented z7% and .10% of all splenic cells by 6 and 12
wk, respectively, after the transfer (Table I, and data not
shown). The presence of high numbers of IgM-secreting B
cells in RAG-22/2 mice transferred with aly/1 PEC cells
and yet reduced numbers of B2201IgM1 cells (1/3 of those
in normal mice) in spleen suggests that peritoneal B cells
may contain precursors to plasma cells or differentiate rap-
idly to plasma cells after transfer.
The difference in the numbers of plasma cells between
RAG-22/2 mice injected with aly/aly and aly/1 PEC cells
was also reflected in the serum levels of Igs, as shown in
Fig. 3. In RAG-22/2 mice, 6 wk after transfer of aly/aly
PEC cells, the serum titers of IgM and IgG were very low
compared with those injected with aly/1 PEC cells, and
the IgA levels were not detected, even after 6 wk.
The percentages and numbers of aly/aly T cells that mi-
grated to LP and MLNs 3 wk after the transfer into RAG-
22/2 mice were four to six and two times less, respectively,
than those of aly/1 T cells (Fig. 4, A and B, and data not
shown). Although T cells from aly/aly PEC have a migra-
tion defect to the GALT system, their homing to spleen
and BM was unaffected (Fig. 4 B). These results suggest
that chemokines involved in homing of B and T cells to
spleen may be different from those necessary for their mi-
gration to the GALT system. Alternatively, if the same
chemokines are involved, they probably use different sig-
naling pathways.
Both Chemokines and Their Receptors Are Expressed in aly/
aly Mice.  To explore the cause of the migration defect of
aly/aly PEC cells, we measured mRNA expression levels of
chemokines and their receptors. We first studied the
mRNA expression of SLC, ELC (also known as macro-
phage inflammatory protein 3b), and BLC in the spleen and
small intestine, to which PEC cells were shown to migrate
in RAG-22/2 mice. As shown in Fig. 5 A, SLC mRNA was
expressed in the spleen and small intestine of RAG-22/2
Figure 3. Isotype of serum Ig in RAG-22/2 mice injected with PEC
cells from aly/aly (j) and aly/1 (s) mice. Serum Ig levels were deter-
mined 3 or 6 wk after transfer, by isotype-specific ELISA. Results repre-
sent mean 6 SE from three separate experiments.
Figure 4. Migration defect of aly/aly peritoneal T cells to the GALT
system. (A) Flow cytometric analysis of LP cells derived from RAG-22/2
mice and RAG-22/2 mice transferred with 1.3 3 107 PEC cells from aly/
aly and aly/1 mice 6 wk previously. A total of 2 3 104 cells were ana-
lyzed for CD3 in combination with Mac-1. The numbers are the per-
centages of T (CD31Mac-12) cells. (B) Numbers of T cells recovered 3–6
wk after transfer, calculated by multiplying total cell number with the
percentage of T cells in indicated lymphoid tissues. Results represent
mean  6  SE from three different experiments.
Figure 5. Chemokine and chemokine receptor expression in aly/aly
mice. (A) Chemokine expression in spleen and small intestine of RAG-
22/2, aly/aly, and aly/1 mice. Northern blot analysis of total RNA from
spleen and small intestine of RAG-22/2 mice and aly/aly mice, and small
intestine with or without PPs from aly/1 mice, and probed to detect ex-
pression of SLC, ELC, and BLC. (B) Chemokine receptor expression in
spleen and PEC cells from aly/aly and aly/1 mice. LPS stimulation mark-
edly increased the expression of CCR7 and BLR1 RNA in peritoneal
cells of aly/1 but not aly/aly mice. Northern blot analysis of total RNA
from unstimulated and LPS-stimulated (20 mg of LPS for 2 h) splenic and
PEC cells and probed to detect expression of CCR7 and BLR1. GAPDH
hybridization indicates amount of total RNA loaded in each lane.1482 aly Defect in Chemokine Receptor Signaling and Homing
mice and aly/aly mice, albeit at lower levels than in aly/1
mice. ELC mRNA expression levels were lower in spleen
and absent or lower in small intestine of both RAG-22/2
and aly/aly mice compared with aly/1 mice. BLC mRNA
expression was drastically reduced in spleen and absent in
small intestine of RAG-22/2 and aly/aly mice. Therefore,
among the chemokines constitutively expressed in second-
ary lymphoid organs, SLC mRNA was found most abun-
dantly expressed in RAG-22/2 mice, suggesting that this
chemokine could be important for homing of injected lym-
phocytes to the lymphoid tissues of RAG-22/2 mice.
We also found that both PEC and spleen cells of aly/aly
and aly/1 mice expressed at least detectable levels of CCR7
and BLR1 (Fig. 5 B). BLR1 mRNA expression levels of
spleen and PEC cells from both aly/aly and aly/1 mice
were upregulated after LPS stimulation. On the other hand,
CCR7 mRNA expression was not affected except for aly/1
PEC cells, probably because CCR7 mRNA was abun-
dantly expressed in spleen cells even without in vitro activa-
tion.
Reduced Chemotactic Activities of SLC and BLC on Resting
and LPS-activated aly/aly Peritoneal Lymphocytes.  Based on
the mRNA expression profiles of chemokines and their re-
ceptors, we assayed chemotactic responses of aly/aly and
aly/1 PEC cells to two chemokines: SLC and BLC. As
shown in Fig. 6 A, peritoneal B1 cells from aly/aly mice did
not respond to SLC at all, whereas those from aly/1 mice
responded to SLC. aly/aly peritoneal B2 and T cells also
showed very weak chemotactic responses to SLC compared
with those from aly/1 mice (Fig. 6, B and C). Interestingly,
splenic B and T cells of aly/aly mice showed a normal
chemotactic response to SLC (Fig. 6, D and E). BLC in-
duced a very weak chemotactic response in peritoneal B1
and B2 cells of aly/aly mice. On the other hand, BLC in-
duced a strong chemotactic response in peritoneal B1 and
B2 cells and splenic B cells of aly/1 mice, as well as in
splenic B cells of aly/aly mice (Fig. 6, F–H). As expected,
BLC showed limited activity toward T cells (data not
shown).
LPS activation was found to enhance the chemotactic re-
sponse to SLC and BLC of peritoneal but not of splenic B
cells (Fig. 6). Although aly/aly peritoneal B lymphocytes
showed an increase in the chemotactic response to SLC af-
ter LPS stimulation, their responses were still weaker than
those of nonstimulated aly/1 peritoneal B cells. By con-
trast, LPS stimulation augmented the BLC responsiveness of
aly/aly PEC B cells to similar levels as nonstimulated aly/1
PEC B cells, in agreement with upregulation of BLR1
mRNA by LPS stimulation (Fig. 5 B). The increased re-
sponsiveness of activated PEC B cells to SLC and BLC did
not reflect an increase in the spontaneous mobility of B
cells, as there was no difference in the migration frequency
in the absence of chemokines between activated and nonac-
tivated B cells.
NIK Is Downstream of SLC Receptor Signaling.  aly/aly
PEC cells failed to migrate to the GALT system as well as to
the spleen. The in vivo migration defect of aly/aly PEC
cells correlates well with the in vitro defective chemotactic
response of aly/aly PEC cells to SLC and BLC. This migra-
tion defect cannot be explained by the lack of chemokines
or their receptors, suggesting that the signal downstream of
chemokine receptors might be affected in aly/aly mice.
Therefore, we examined whether chemokine-induced NF-
kB activation is affected by the aly mutation of NIK. We
Figure 6. Decreased chemotactic activity of SLC
and BLC on resting and acutely activated PEC cells
from aly/aly mice compared with aly/1 mice. The
number of input and migrating cells of each subtype
was determined by immunostaining and flow cytome-
try. Results are expressed as the percentage of input
cells of each subtype migrating to the lower chamber of
a Transwell filter. Graphs show migration of: (A) PEC
B1 cells; (B) PEC B2 cells; (C) PEC T cells; (D) spleen
B cells; (E) spleen T cells, towards SLC; (F) PEC B1
cells; (G) PEC B2 cells; and (H) spleen B cells towards
BLC. PEC cells and spleen cells were preincubated
with medium alone (LPS2) or LPS at 20 mg/ml for 3 h.
Data points represent the mean 6 SE for experiments
performed in triplicate. Each experiment was repeated
at least three times.1483 Fagarasan et al.
stimulated PEC cells from aly/aly and aly/1 mice with
SLC, and the activation of NF-kB was determined by the
gel shift assay of nuclear extracts, 15 or 30 min after stimula-
tion. As shown in Fig. 7, SLC stimulation did not induce
activation of NF-kB in aly/aly PEC, but increased the levels
of NF-kB in the nuclei of aly/1 PEC. The same stimula-
tion did not affect the amount of Oct-1 transcription factor
in the nuclear extract of either aly/aly or aly/1 PEC cells.
Although the SLC-induced activation of NF-kB was not
observed in nuclei of aly/aly PEC cells, the NF-kB com-
plexes were present even before SLC stimulation. What was
different from aly/1 PEC cells was not the constitutive
level, but rather the species of the NF-kB complexes. The
supershift assay (Fig. 8) indicated that the NF-kB complexes
in  aly/aly PEC cells consisted mostly of p50-p50 ho-
modimers and p50-p65 heterodimers because anti-p65 and
anti-p50 mAbs formed supershifted bands in aly/aly nuclear
extracts. On the other hand, the NF-kB complexes in aly/1
PEC cells contained mainly p50-p50 homodimers. These
results clearly demonstrate that NIK acts downstream of the
signaling pathway of the receptors for SLC, leading to acti-
vation of the NF-kB complex. In addition, the aly-type
mutation in the NIK gene affects this signaling pathway, re-
sulting in the migration defect of aly/aly PEC cells.
Discussion
The absence of secondary lymphoid tissues such as LNs
and PPs in LTa2/2, LTbR2/2, and aly/aly mice is now
clearly explained by the defect in the common signaling
pathway using LTbR and NIK (14). Because NIK appears
to be ubiquitously expressed in the mouse (our unpublished
data), and the aly/aly phenotype is more severe than that of
LTbR2/2 mice, we considered the possibility that the NIK
mutation affects the signaling pathways of other receptors in
lymphoid as well as nonlymphoid cells. We have shown by
in vivo and in vitro experiments that aly/aly PEC cells have
a defect that affects their homing capacity, especially to the
GALT system. The in vivo migration defect of aly/aly PEC
cells correlated well with the in vitro impaired chemotactic
response toward SLC and BLC. We found that SLC stimu-
lation did not activate NF-kB in aly/aly PEC cells, whereas
the same stimulation increases the nuclear NF-kB in aly/1
PEC cells, thus demonstrating that NIK is located down-
stream of the signaling pathway through the receptors for
SLC, and that aly-type NIK affects this pathway. NIK is
known to participate in the signaling cascade responsible for
NF-kB activation through receptors of the TNF and IL-
1R/toll-like receptor (TLR) families (38–44) including
LTbR, TNFR, CD40, and CD95. In this study, we have
shown that the receptors for SLC also use NIK for NF-kB
activation. In agreement with this, we found that overex-
pression of CCR7 in 293T cells induced NF-kB activation
in an NIK-dependent manner (our unpublished data).
Chemokine receptors including BLR1 and CCR7 are
seven transmembrane receptors that are coupled with G
proteins for signal transduction (45–48). This is the first re-
port that a G protein–coupled receptor is also involved in
NF-kB activation through NIK.
It has been reported that except for the mucosal ad-
dressin cell adhesion molecule 1 (MAdCAM-1) in the
spleen, the expression of lymphocyte adhesion molecules
and their cognate receptors is similar in aly/aly and aly/1
mice (49). In this study, we have shown that aly/aly lym-
phocytes also have normal expression levels of chemokine
receptor mRNAs in spleen and PEC cells. The reduced
levels of chemokine expression in aly/aly mice were proba-
bly due to the severe defect of stromal cells that have been
shown to produce chemokines necessary for B and T com-
partmentalization in the spleen (50). At the same time, the
lymphoid cell depletion, in particular B cell depletion in
spleen of aly/aly mice, may also contribute to the reduced
level of BLC, as it is known that B lymphocytes are impor-
tant for induction of BLC expression, by providing
LTa1b2 and possibly TNF (50). Although the chemokine
mRNA expression was reduced in spleen and small intes-
tine of aly/aly compared with aly/1 mice, the chemokine
mRNA expression levels were higher in aly/aly mice than
in RAG-22/2 mice, which can support homing of normal
peritoneal B and T cells to the GALT system and spleen.
These results suggest that aly/aly PEC cells may have an in-
trinsic defect that affects their homing capacity, especially
to the GALT system. However, we cannot completely ex-
Figure 7. Impaired activation of NF-kB by SLC in aly/aly PEC cells.
Nuclear proteins (6 mg) from unstimulated and SLC (500 ng/ml) stimu-
lated PEC cells for 15 or 30 min, were incubated with unlabeled (cold
competitor, WT comp) and mutant (Mut comp) NF-kB probe for 20
min. The samples were then incubated with 32P-labeled NF-kB sequence
for 20 min, followed by separation on polyacrylamide gel and analysis by
autoradiography. The Oct-1–specific probe was used as internal control.
Figure 8. The NF-kB complexes are different in PEC cells from aly/
aly and aly/1 mice. Nuclear extracts from PEC cells stimulated for 30
min with SLC were incubated with the indicated antibody followed by
32P-labeled NF-kB sequence. The samples were migrated on polyacryla-
mide gels and analyzed by autoradiography. (A) p65-cRel/p65-RelB
complex, (B) p50-p65/p50-RelB complex, and (C) p50-p50 complexes.1484 aly Defect in Chemokine Receptor Signaling and Homing
clude alternative explanations, that the failure of PEC cell
migration to lymphoid tissues is due to extrinsic defects
such as differences in cytokines released by T cells and
macrophages of aly/aly and aly/1 mice, or differences in
the ability of aly/aly and aly/1 lymphocytes to induce up-
regulation of chemokines by stromal cells.
The inability to recover Ig levels by aly/aly PEC cells
correlates well with the observation that aly/aly PEC B cells
gave rise to a few IgM and IgG plasma cells in the spleen,
and no plasma cells in the GALT system of RAG-22/2
mice. Therefore, the migration capacity of B cells appears
to be closely related to their ability to produce antibodies
that were affected in aly/aly mice. We found that aly/1
PEC B and T cells migrate to all lymphoid tissues of RAG-
22/2 mice. PEC B cells that migrated to the GALT system
differentiated mainly to IgA plasma cells, whereas those mi-
grated to spleen expressed predominantly IgM and IgG.
We detected a large number of B2202IgA1 cells in MLNs
of RAG-22/2  mice transferred with aly/1 PEC cells.
Though in normal mice B2202IgA1 plasma cells could be
found mainly in LP and represent ,1% of the lymphocytes
in MLNs (our unpublished data), in RAG-22/2 mice this
population represented z12% of the lymphocytes in
MLNs, 6 wk after transfer. The absolute numbers of IgA
plasma cells were also two times higher in MLNs than in
LP of these mice. This observation suggests that PEC B cell
proliferation and differentiation to IgA plasma cells may
take place in the MLNs, although we cannot exclude the
possibility that this phenomenon is restricted to the RAG-
22/2 environment, which is probably devoid of normal reg-
ulatory mechanisms.
We still do not know which chemokines are involved in
PEC cell migration in vivo. As blr12/2 mice, which lack
PPs and therefore the B2 cell precursors of plasma cells,
have normal IgA-producing cells in LP (23), the impaired
chemotactic response to BLC is unlikely to be the major
cause of the aly/aly PEC cell migration defect to the GALT
system. Regardless of which chemokines or chemokine re-
ceptors are involved in the PEC cell migration, it is likely
that NIK is involved in their signaling pathways.
Interestingly, the in vitro chemotactic response of splenic
cells to SLC and BLC was very similar between aly/aly and
aly/1 mice, indicating that chemotactic responses of
splenic and PEC cells are regulated differently. The differ-
ence could be explained first by the different microenvi-
ronments in spleen and PEC, which could affect the activa-
tion status of cells partially reflected in the chemokine
receptor expression levels. Supporting this notion, LPS
stimulation upregulated the levels of chemokine receptor
mRNA expression and increased the migration capacity of
peritoneal but not splenic cells (Fig. 5 B, and Fig. 6). Sec-
ond, it is also possible that splenic and PEC cells use differ-
ent chemokine receptors, and the pathway involving NIK
is important only for PEC cells migration.
This study offers an explanation for their complex and
severe aly phenotype, showing that the migration defect of
lymphocytes to the proper places is also responsible for the
immunological abnormalities in aly/aly mice.
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